Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera - PubMed (original) (raw)
. 1997 Feb 28;272(9):5966-73.
doi: 10.1074/jbc.272.9.5966.
Affiliations
- PMID: 9038217
- DOI: 10.1074/jbc.272.9.5966
Free article
Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera
T Tenev et al. J Biol Chem. 1997.
Free article
Abstract
The previously demonstrated functional and physical interaction of the SH2 domain protein-tyrosine phosphatase SHP-1 with the epidermal growth factor (EGF) receptor (Tomic, S., Greiser, U., Lammers, R., Kharitonenkov, A., Imyanitov, E., Ullrich, A., and Böhmer, F. D. (1995) J. Biol. Chem. 270, 21277-21284) was investigated with respect to the involved structural elements of SHP-1. Various mutants of SHP-1 were transiently expressed in 293 or COS-7 cells and analyzed for their capacity to associate with immobilized autophosphorylated EGF receptor in vitro and to dephosphorylate coexpressed EGF receptor in intact cells. Inactivating point mutation of the C-terminal SH2 domain reduced the association weakly, point mutation of the N-terminal SH2 domain reduced association strongly and the respective double mutation abolished association totally. The capacity of SHP-1 to dephosphorylate coexpressed EGF receptor was impaired by all point mutations. Truncation of the N-terminal or of both SH2 domains strongly reduced or abolished association, respectively, but the truncated SHP-1 derivatives still dephosphorylated coexpressed EGF receptor effectively. Various chimeric protein-tyrosine phosphatases constructed from SHP-1 and the closely homologous SHP-2 dephosphorylated the EGF receptor when they contained the catalytic domain of SHP-1. As native SHP-2, the chimera lacked activity toward the receptor when they contained the catalytic domain of SHP-2, despite their capacity to associate with the receptor and to dephosphorylate an artificial phosphopeptide. We conclude that the differential interaction of SHP-1 and SHP-2 with the EGF receptor is due to the specificity of the respective catalytic domains rather than to the specificity of the SH2 domains. Functional interaction of native SHP-1 with the EGF receptor requires association mediated by both SH2 domains.
Similar articles
- Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K, Böhmer FD. Keilhack H, et al. J Biol Chem. 1998 Sep 18;273(38):24839-46. doi: 10.1074/jbc.273.38.24839. J Biol Chem. 1998. PMID: 9733788 - Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.
Barford D, Neel BG. Barford D, et al. Structure. 1998 Mar 15;6(3):249-54. doi: 10.1016/s0969-2126(98)00027-6. Structure. 1998. PMID: 9551546 Review. - Shp-2 tyrosine phosphatase: signaling one cell or many.
Feng GS. Feng GS. Exp Cell Res. 1999 Nov 25;253(1):47-54. doi: 10.1006/excr.1999.4668. Exp Cell Res. 1999. PMID: 10579910 Review.
Cited by
- The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation.
Forbes K, Skinner L, Aplin JD, Westwood M. Forbes K, et al. Cell Mol Life Sci. 2012 Dec;69(23):4029-40. doi: 10.1007/s00018-012-1067-5. Epub 2012 Jul 15. Cell Mol Life Sci. 2012. PMID: 22797910 Free PMC article. - Structural and evolutionary relationships among protein tyrosine phosphatase domains.
Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Møller NP. Andersen JN, et al. Mol Cell Biol. 2001 Nov;21(21):7117-36. doi: 10.1128/MCB.21.21.7117-7136.2001. Mol Cell Biol. 2001. PMID: 11585896 Free PMC article. Review. No abstract available. - Protein tyrosine phosphatase function: the substrate perspective.
Tiganis T, Bennett AM. Tiganis T, et al. Biochem J. 2007 Feb 15;402(1):1-15. doi: 10.1042/BJ20061548. Biochem J. 2007. PMID: 17238862 Free PMC article. Review. - Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling.
Tighe AP, Talmage DA. Tighe AP, et al. Exp Cell Res. 2004 Dec 10;301(2):147-57. doi: 10.1016/j.yexcr.2004.07.008. Exp Cell Res. 2004. PMID: 15530851 Free PMC article. - Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1.
Keilhack H, Müller M, Böhmer SA, Frank C, Weidner KM, Birchmeier W, Ligensa T, Berndt A, Kosmehl H, Günther B, Müller T, Birchmeier C, Böhmer FD. Keilhack H, et al. J Cell Biol. 2001 Jan 22;152(2):325-34. doi: 10.1083/jcb.152.2.325. J Cell Biol. 2001. PMID: 11266449 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous